Formerly known as Orchid Life, Medika Natura is a pioneer in the end-to-end development, production and commercializing of botanical bio-active compounds native to Southeast Asia.
SKF7™ approved to be sold in the United States via Amazon
Medika Natura’s flagship ingredient, SKF7™ is set to reach American shores by early 2021 via Amazon following USFDA approval.
Medika Natura CEO, Abdul Razak Mohd Isa, has been appointed as subject matter expert in research and development (R&D) with the Malaysian Ministry of Science, Technology and Innovation (MOSTI)...
Medika Natura CEO, Abdul Razak Mohd Isa, has been appointed as an Adjunct Professor at the Institute of Systems Biology (INBIOSIS) at the National University of Malaysia (UKM) Razak’s two-year...
Phase 2 clinical studies of SKF7™ conducted in Indonesia is the first Malaysian-led anti-obesity study to be registered on ClinicalTrials.gov, the world’s largest clinical trial database. Medika...
MEET MEDIKA NATURA
NEED HELP?
FOLLOW US